Mounjaro 5mg KwikPen contains Tirzepatide, a dual GIP and GLP-1 receptor agonist used for type 2 diabetes management. It is taken once a week and helps with weight loss and blood sugar control.

Brand Name: Mounjaro

Composition: Tirzepatide

Mechanism of Action:

A dual GIP and GLP-1 receptor agonist, tirzepatide aids in controlling blood sugar levels in people with type 2 diabetes. It functions by slowing stomach emptying, which raises satiety and may aid in weight loss, decreasing glucagon levels to lower blood sugar, and increasing insulin production in response to meal consumption.

Uses:

·       Type-2 Diabetes Mellitus

·       Weight Management

Dosage and Administration:

·       5 mg once weekly subcutaneously (abdomen, thigh, or upper arm, rotating sites) is the recommended dosage.

·       This dose, which is the first therapeutic dose for glycemic control, is given following four weeks of 2.5 mg.

·       If necessary, the dosage can be raised by 2.5 mg every 4 weeks, with a weekly maximum of 15 mg.

·     It can be administered at any time of day, with or without food; if it is missed, take it within four days; if not, skip it and carry on with your usual routine.

Side Effects:

·       Nausea

·       Vomiting

·       Diarrhea

·       Constipation

·       Decreased appetite

·       Injection site reactions (Itching, Rashes)

·       Hypoglycemia

Safety Advise:

Lungs  

The safety of Mounjaro for individuals with lung issues is uncertain. Kindly speak with your healthcare provider.

Liver  

The safety of Mounjaro for individuals with liver issues is uncertain. Kindly speak with your healthcare provider.

Kidney  

The safety of Mounjaro for individuals with Kidney issues is uncertain. Kindly speak with your healthcare provider.

Pregnancy  

Mounjaro should be used during pregnancy only if clearly needed, Kindly speak with your healthcare provider.

Breast Feeding  

Using Mounjaro while nursing is most likely dangerous. Kindly speak with your healthcare provider. 

Storage:

Avoid freezing the Mounjaro KwikPen and keep it in a refrigerator between 2°C and 8°C. After usage, it can be stored for 21 days at room temperature (up to 30°C) under protection from heat and light.

How to use this Medication?

This drug is administered subcutaneously. You'll learn how to prepare and administer it. It is administered once every seven days, or once a week. Unless instructed otherwise by your healthcare provider, continue taking it.

You should inject this medication and insulin separately if you take both together. Don't combine them. Avoid administering the shots directly close to one another. With every injection, rotate the injection sites.

References:

1.   Baker DE, Walley K, Levien TL. Tirzepatide. Hospital Pharmacy. 2023 Jun;58(3):227-43.

2.  Karagiannis T, Avgerinos I, Liakos A, Del Prato S, Matthews DR, Tsapas A, Bekiari E. Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis. Diabetologia. 2022 Aug;65(8):1251-61.

3.  Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022 Jul 21;387(3):205-16.

4.  Chavda VP, Ajabiya J, Teli D, Bojarska J, Apostolopoulos V. Tirzepatide, a new era of dual-targeted treatment for diabetes and obesity: a mini-review. Molecules. 2022 Jul 5;27(13):4315.

Disclaimer:

The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.

Marketer details

Name: Eli Lilly and Company India Pvt Ltd

Address: Plot# 92, Sector 32, Institutional Area, Gurgaon-122001, HARYANA, INDIA

Country of origin: United states

Frequently Asked Questions:

1. What is Mounjaro 5mg KwikPen?
Mounjaro 5mg KwikPen is a prefilled auto-injector containing Tirzepatide 5mg. It is prescribed in the management of Type 2 diabetes and may assist in blood sugar regulation. In some patients, it may also be associated with weight changes. Please consult your doctor for guidance specific to your health needs.

2. How does Mounjaro 5mg KwikPen work?
It is believed to act as a dual GIP and GLP-1 receptor agonist. This may stimulate insulin release in a glucose-dependent manner, suppress glucagon, slow gastric emptying in some patients, and potentially reduce appetite. The degree of these effects may vary between individuals.

3. How is the Mounjaro 5mg KwikPen administered?
It is intended to be injected subcutaneously once a week. Recommended injection sites typically include the abdomen, thigh, or upper arm. Your healthcare provider will advise on proper technique.

4. When is the dose increased from 2.5mg to 5mg?
After approximately 4 weeks on the 2.5mg dose, a physician may consider increasing the dose to 5mg, based on the individual patient's tolerance and blood sugar response. This decision should always be made by your doctor.

5. Can I inject Mounjaro at any time of the day?
Mounjaro may generally be injected at any time of the day, with or without food. It is recommended to administer it on the same day each week for consistency. Follow your doctor's instructions regarding timing.

6. What if I miss a dose?
If a dose is missed, it may be administered as soon as possible within 4 days of the missed dose. If more than 4 days have passed, it is generally advised to skip the missed dose and resume the regular weekly schedule. Always consult your doctor or pharmacist if you are unsure.

7. What are the possible side effects?
Some patients may experience:
•         Nausea
•         Diarrhoea
•         Vomiting
•         Constipation
•         Abdominal discomfort
These effects may vary in frequency and severity. Not all patients will experience them. Consult your doctor if side effects are troublesome.

8. Can Mounjaro 5mg be used with insulin?
Mounjaro may be used alongside insulin under medical supervision, though combining the two may increase the risk of hypoglycaemia (low blood sugar) in some patients. Dose adjustments may be required. Your doctor will guide the appropriate treatment combination for your situation.

9. Is Mounjaro 5mg suitable for patients with kidney disease?
Patients with pre-existing kidney conditions may require additional caution when using Mounjaro, as dehydration resulting from gastrointestinal side effects could potentially affect kidney function in some individuals. Please consult your nephrologist or physician for personalised advice.

10. How should the KwikPen be disposed of?
Used pens should be discarded in an approved sharps disposal container. Needles should not be reused, and pens must never be shared between patients.

11. Is Mounjaro 5mg KwikPen available over the counter?
No. It is a prescription-only medicine and is available only through licensed pharmacies upon presentation of a valid doctor's prescription.

Medical Disclaimer:
Mounjaro 5mg KwikPen is a prescription-only medicine and must be used strictly under the supervision and guidance of a qualified healthcare professional. Do not self-medicate, alter the dosage, or discontinue use without consulting your doctor. The information provided here is for educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Individual results, benefits, and risks may vary. Always consult your physician before starting, changing, or stopping any medication.